Georgia Bio to Showcase State’s Leadership and Patients’ Perspectives in Bioscience Innovation at 2019 Innovation Summit

Atlanta, Georgia (September 26, 2019) – The Georgia Bio Innovation Summit is the southeast’s largest life science conference, showcasing Georgia’s leadership in innovation to improve the health and well-being of people, animals and the environment. This year’s Summit will bring together hundreds of CEOs, senior executives, scientists and public policy officials from Georgia and across the nation on October 8 at the Cobb Galleria in Atlanta.

How important is the life sciences industry to the state of Georgia? From 2007 to 2017, employment in life sciences grew by 14.9%, compared to 7.7% nationally, and 8.7% growth in private employment across all industries in the state.” An RTI report for Georgia Bio published earlier this year identified 1,960 unique life science establishments that contributed 68,300 jobs and $10 billion to Georgia’s Gross Domestic Product. Accounting for multiplier effects, the industry supports a total of approximately 194,000 jobs and contributes $21.8 billion to Georgia’s GDP.

The 2019 Breakfast Keynote is entitled ”Connecting Healthcare” from Dr. Jean-Christophe Tellier, UCB Global CEO. The Luncheon Keynote Address “Personalized Health in a Chaotic Environment” will be delivered by Marc Boutin, CEO of the National Health Council

“In order to innovate, first and foremost, we must connect the patient to the science,” Tellier told the Harvard Club of Belgium. “We are moving from treating the group of patients on one criteria [towards] a better understanding of patient subpopulations and trying to define much more precise solutions that better match their needs based on biologic signatures.”

Georgia Bio is putting special emphasis on the patient’s perspective into this year’s event. What does patient-centricity really mean in an industry that comprises 20 percent of the U.S. economy? We will hear from four local members of the International Children’s Advisory Network; young advocates for the importance of the patient’s voice in pediatric care. High school senior Ayana Ganesh, sophomore Ava Meisner, eighth grader Kalee Polk, junior Maci Yeager and moderator Leanne West who will share their first person accounts of what patient centricity and the importance of the patient voice means in pediatric care.

View the full program agenda here.

Did you know, according to AdvaMed, Fortune 500 companies with more than three women on the Board have 66% higher return on invested capital and a 42% higher return on sales?

Given those statistics, to ensure we hear directly from the voice of the patient, and to build awareness among aspiring young women for what is attainable in our industry, we have intentionally stacked our presenting faculty with women leading the state’s life science sector. Read more about the industry leading women in Georgia’s life sciences presenting. 

“We are entirely confident the 2019 edition of the Georgia Bio Innovation Summit will be of high value for any and all with an interest in Georgia’s life science community and driving better treatments and care to patients in Georgia and around the globe,” says Georgia Bio President and CEO Maria Thacker-Goethe.

Register here

About Georgia Bio

Georgia Bio is the state’s trade association committed to driving growth in Georgia’s biosciences industry and its many sectors, including agri-biotech, food and nutrition, bio-based technologies and renewable chemicals, industrial and environmental biotech, medical devices and technologies, pharmaceuticals and consumer healthcare, diagnostics and research products, testing and research services, and clinical research. Georgia Bio members include bioscience companies, academic and research institutions, bioscience service providers, digital health companies, and related organizations. For more information, visit www.gabio.org or follow us on Twitter @Georgia_Bio

Editor’s Note: Registration is complimentary for credentialed members of the news media. To request media registration, please contact Kristina Forbes at kforbes@gabio.org | 404-920-2043. 

Media Contact: 
Kristina Forbes
404-920-2043
kforbes@gabio.org

By Maria Thacker Goethe April 18, 2025
The Science & Community Impacts Mapping Project (SCIMaP) shows how proposed federal funding cuts lead to reduced economic activity and job losses nationwide.
By Sheran Brown April 10, 2025
Georgia Life Sciences Selects Fulton County Schools Innovation Academy Student as the 2025 Georgia BioGENEius Winner Sandy Springs & Rockmart Teens Take Top Honors in Statewide Science Competition Atlanta, GA (April 4, 2025) – Georgia Life Sciences today named Bhavya Alapati , a junior at Fulton County Schools Innovation Academy, as the winner of the 2025 Georgia BioGENEius Challenge, the premier competition for high school students that recognizes outstanding research and innovation in the biotechnology field. Eleven students from across Georgia competed for this year’s title and cash prize. Bhavya’s project investigated a novel method of identifying strokes using a device she created called SpectroStroke, a small-scale spectrophotometer, to detect homocysteine, an amino acid product that is associated with stroke. Bhavya identified the ability of homocysteine to be detected using Ellman’s reagent, which reacts with the free sulfhydryl group on the molecule to produce a yellow color. Bhavya created a wearable patch that contains the Ellman’s reagent. Then, she designed the SpectroStroke to be able to detect the color change when the patch is exposed to elevated levels of homocysteine. Bhavya’s SpectroStroke can detect normal levels of homocysteine up to extremely high levels seen in those experiencing a stroke. The ability to detect a stroke earlier would reduce damage and long-term effects of the condition. A future iteration of the SpectroStroke would include real-time monitoring capabilities to help track changing homocysteine levels. "Supporting and celebrating outstanding research and innovation in biotechnology is vital for the future of science and medicine. The Georgia BioGENEius Challenge not only encourages the brightest young minds to explore their potential but also nurtures the next generation of leaders who will drive groundbreaking advancements in biotechnology,” said Georgia Life Sciences President and CEO Maria Thacker-Goethe. “By recognizing and empowering these students, we are helping to shape a future where innovation thrives and the possibilities for improving lives are endless. Well done, Bhavya!” Georgia Life Sciences also congratulates the Georgia BioGENEius runner-up, Shelby Kendrick , who is a senior at Paulding County High School in Dallas, GA. Shelby’s research investigated the ability of Aspergillus terreus, a fungus found in soil, to degrade pre-treated polypropylene plastic (PP). This fungus has been discovered to produce high concentrations of degrading enzymes and raises the moisture level of its substrate. Shelby isolated the fungus from soil samples and confirmed the species using PCR amplification and DNA barcoding. Samples of polypropylene were pre-treated with 75% ethanol and UV exposure, then placed in a liquid culture of A. terreus in Minimal Salt Medium (MSM) media, and the culture was incubated for 23 days. At the end of the trial period, PP samples were analyzed using Scanning Electron Microscopy. These samples showed changes in their surface layer, indicating evidence of biodegradation. Polypropylene plastic is found in household items such as plastic cups and is a known problem in the environment due to its inability to degrade. Shelby’s future research on the use of A. terreus for biodegradation includes optimizing degradation conditions and assessing methods of application in the environment. Judging the 2025 Georgia BioGENEius Challenge were Ralph L. Cordell, CDC, and Alex Harvey, ViaMune. Cash prizes were awarded to Bhavya and Shelby. # # # About Georgia Life Sciences Georgia Life Sciences, founded in 1989, is a non-profit, membership-based organization that promotes the interests and growth of the life sciences industry. It is the state’s largest and most influential life sciences advocacy and business leadership organization working to improve access to innovative discoveries that have lifesaving impact. The association connects business, academia, government, and other allied entities involved in the application of life sciences products to fuel growth and collaboration through policy development, community programs, national industry initiatives, and a portfolio of educational and networking events. Learn more at galifesciences.org.
By Maria Thacker Goethe April 9, 2025
Emerging biotechnology is key for U.S. to remain dominant and secure future economic growth in a new era of global competition
MORE POSTS